Concerta shortage notification extended again

Regulator warns shortages of some methylphenidate hydrochloride products are likely to continue until late 2026  Manufacturing issues have prompted Jassen-Cilag to extend its shortage notification for varying strengths of its Concerta modified-release tablets through to 31 December 2026.  The Therapeutic Goods Administration (TGA) said the supply issues will impact Concerta 18 mg, 27 mg, 36